VO-101

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVO-101
Drug Alias Nameprocaspase-3-targeting compounds (Vanquish Oncology)S-PAC-1 (Vanquish Oncology)VO-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCaspase-3 stimulants
TargetsCaspase-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVanquish Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVanquish Oncology Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A